MANKIND - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 20 Dec 25, 03:55 pm

Technical Rating: 2.8

📉 Chart Patterns & Trend: MANKIND is trading at ₹2,174, below both its 50 DMA (₹2,279) and 200 DMA (₹2,402). This indicates a bearish reversal with weak momentum and declining trendlines. The stock is near its recent low of ₹2,090, suggesting vulnerability.

📊 Moving Averages: Price below both short- and long-term averages confirms bearish sentiment. Key support lies near ₹2,090, while resistance is around ₹2,280–₹2,400.

📉 RSI: At 35.3, RSI is close to oversold territory, signaling weak momentum but potential for a short-term bounce.

📉 MACD: Negative MACD (-47.7) reinforces bearish momentum, showing strong downward pressure.

📉 Bollinger Bands: Price is near the lower band, indicating oversold conditions. A rebound toward mid-band (~₹2,250) is possible.

📊 Volume Trends: Current volume (4.26L) is below the weekly average (6.51L), showing reduced participation and lack of strong buying interest.

🎯 Entry Zone: ₹2,100–₹2,150 (near support)

🚪 Exit Zone: ₹2,280–₹2,350 (near resistance)

Positive

• Quarterly PAT improved from ₹413 Cr. to ₹459 Cr., showing earnings growth.
• DII holding increased (+0.41%), reflecting domestic institutional confidence.
• Strong ROCE (15.0%) and ROE (13.9%) indicate efficient capital utilization.

Limitation

• Stock trading below both 50 DMA and 200 DMA indicates bearish momentum.
• High P/E (53.8) compared to industry PE (30.6) suggests overvaluation.
• Dividend yield at 0.05% is negligible for income investors.
• PEG ratio of 6.40 highlights expensive valuation relative to growth.

Company Negative News

• Quarterly profit variation (-25.2%) shows earnings volatility.
• FII holding decreased (-0.24%), indicating reduced foreign investor confidence.

Company Positive News

• Strong domestic institutional support with DII holdings rising.
• Consistent profitability with EPS of ₹40.4.
• Solid fundamentals with manageable debt-to-equity ratio (0.47).

Industry

• Industry PE at 30.6 is lower than MANKIND’s PE (53.8), suggesting premium valuation.
• Pharma sector growth driven by generics, specialty drugs, and healthcare demand.

Conclusion

📌 MANKIND is in a bearish reversal, trading below key moving averages with negative MACD and weak RSI. Entry near ₹2,100–₹2,150 may offer short-term bounce potential, while resistance at ₹2,280–₹2,350 limits upside. Despite strong fundamentals and institutional support, high valuation and weak momentum warrant caution in the near term.